NYSE:STE

STERIS Stock Forecast, Price & News

$205.69
+1.56 (+0.76 %)
(As of 06/25/2021 09:45 AM ET)
Add
Compare
Today's Range
$204.70
$205.82
50-Day Range
$188.43
$216.47
52-Week Range
$146.12
$216.74
Volume816 shs
Average Volume691,319 shs
Market Capitalization$17.56 billion
P/E Ratio44.62
Dividend Yield0.78%
Beta0.56
30 days | 90 days | 365 days | Advanced Chart
Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter.


STERIS logo

About STERIS

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

1.95 out of 5 stars

Medical Sector

21st out of 2,118 stocks

Surgical Appliances & Supplies Industry

1st out of 40 stocks

Analyst Opinion: 1.4Community Rank: 2.1Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











STERIS (NYSE:STE) Frequently Asked Questions

Is STERIS a buy right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" STERIS stock.
View analyst ratings for STERIS
or view top-rated stocks.

What stocks does MarketBeat like better than STERIS?

Wall Street analysts have given STERIS a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but STERIS wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting STERIS?

STERIS saw a increase in short interest in May. As of May 28th, there was short interest totaling 3,670,000 shares, an increase of 19.2% from the May 13th total of 3,080,000 shares. Based on an average trading volume of 731,800 shares, the days-to-cover ratio is presently 5.0 days.
View STERIS's Short Interest
.

When is STERIS's next earnings date?

STERIS is scheduled to release its next quarterly earnings announcement on Monday, August 2nd 2021.
View our earnings forecast for STERIS
.

How were STERIS's earnings last quarter?

STERIS plc (NYSE:STE) posted its quarterly earnings data on Tuesday, May, 18th. The medical equipment provider reported $1.63 earnings per share for the quarter, missing the consensus estimate of $1.80 by $0.17. The medical equipment provider had revenue of $873.53 million for the quarter, compared to the consensus estimate of $874.38 million. STERIS had a trailing twelve-month return on equity of 14.17% and a net margin of 12.74%. STERIS's revenue was up 6.1% compared to the same quarter last year. During the same period last year, the company earned $1.64 earnings per share.
View STERIS's earnings history
.

How has STERIS's stock price been impacted by Coronavirus?

STERIS's stock was trading at $145.25 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, STE shares have increased by 40.5% and is now trading at $204.13.
View which stocks have been most impacted by COVID-19
.

How often does STERIS pay dividends? What is the dividend yield for STERIS?

STERIS declared a quarterly dividend on Tuesday, May 18th. Investors of record on Friday, May 28th will be paid a dividend of $0.40 per share on Friday, June 25th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.78%. The ex-dividend date of this dividend is Thursday, May 27th.
View STERIS's dividend history
.

Is STERIS a good dividend stock?

STERIS pays an annual dividend of $1.60 per share and currently has a dividend yield of 0.78%. STERIS has been increasing its dividend for 15 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of STERIS is 25.93%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, STERIS will have a dividend payout ratio of 18.80% next year. This indicates that STERIS will be able to sustain or increase its dividend.
View STERIS's dividend history.

What guidance has STERIS issued on next quarter's earnings?

STERIS issued an update on its FY 2022 earnings guidance on Tuesday, June, 15th. The company provided EPS guidance of $7.400-7.650 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.000. The company issued revenue guidance of $4.50 billion-4.50 billion, compared to the consensus revenue estimate of $3.74 billion.

What price target have analysts set for STE?

5 Wall Street analysts have issued 12 month target prices for STERIS's shares. Their forecasts range from $200.00 to $235.00. On average, they expect STERIS's stock price to reach $225.00 in the next year. This suggests a possible upside of 10.2% from the stock's current price.
View analysts' price targets for STERIS
or view top-rated stocks among Wall Street analysts.

Who are STERIS's key executives?

STERIS's management team includes the following people:
  • Mr. Walter M. Rosebrough Jr., CEO, Pres & Director (Age 67, Pay $2.49M)
  • Mr. Michael J. Tokich, Sr. VP & CFO (Age 52, Pay $1.08M)
  • Mr. Daniel A. Carestio, Sr. VP, COO & Director (Age 48, Pay $1.09M)
  • Mr. John Adam Zangerle, Sr. VP, Gen. Counsel, Sec. (Age 54, Pay $760.33k)
  • Mr. Cary L. Majors, Sr. VP of North America Commercial Operations (Age 46, Pay $690.69k)
  • Ms. Karen L. Burton, Chief Accounting Officer, VP & Controller (Age 53)
  • Julie Winter, VP of Investor Relations & Corp. Communications
  • Ms. Mary Clare Fraser, VP & Chief HR Officer (Age 51)
  • Ms. Julia K. Madsen, Sr. VP of Life Sciences (Age 56)
  • Mr. Renato G. Tamaro, VP & Corp. Treasurer (Age 52)

What is Walter M. Rosebrough, Jr.'s approval rating as STERIS's CEO?

196 employees have rated STERIS CEO Walter M. Rosebrough, Jr. on Glassdoor.com. Walter M. Rosebrough, Jr. has an approval rating of 79% among STERIS's employees.

Who are some of STERIS's key competitors?

What other stocks do shareholders of STERIS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), The Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).

What is STERIS's stock symbol?

STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Who are STERIS's major shareholders?

STERIS's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.03%), WCM Investment Management LLC (7.93%), Massachusetts Financial Services Co. MA (4.93%), Janus Henderson Group PLC (3.74%), Generation Investment Management LLP (3.70%) and Geode Capital Management LLC (1.72%). Company insiders that own STERIS stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, David B Lewis, Jacqueline B Kosecoff, John Adam Zangerle, Julia Madsen, Karen L Burton, Kathleen Bardwell, Mohsen Sohi, Renato Tamaro, Richard C Breeden, Richard Martin Steeves and Walter M Rosebrough Jr.
View institutional ownership trends for STERIS
.

Which institutional investors are selling STERIS stock?

STE stock was sold by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, Morgan Stanley, Allianz Asset Management GmbH, Acadian Asset Management LLC, UBS Group AG, Principal Financial Group Inc., FIL Ltd, and AQR Capital Management LLC. Company insiders that have sold STERIS company stock in the last year include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, David B Lewis, Jacqueline B Kosecoff, John Adam Zangerle, Julia Madsen, Karen L Burton, Richard C Breeden, and Walter M Rosebrough Jr.
View insider buying and selling activity for STERIS
or view top insider-selling stocks.

Which institutional investors are buying STERIS stock?

STE stock was purchased by a variety of institutional investors in the last quarter, including Generation Investment Management LLP, Massachusetts Financial Services Co. MA, APG Asset Management N.V., Ninety One UK Ltd, Alta Capital Management LLC, New York State Common Retirement Fund, Alliancebernstein L.P., and WCM Investment Management LLC.
View insider buying and selling activity for STERIS
or or view top insider-buying stocks.

How do I buy shares of STERIS?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STERIS's stock price today?

One share of STE stock can currently be purchased for approximately $204.13.

How much money does STERIS make?

STERIS has a market capitalization of $17.43 billion and generates $3.11 billion in revenue each year. The medical equipment provider earns $397.40 million in net income (profit) each year or $6.17 on an earnings per share basis.

How many employees does STERIS have?

STERIS employs 13,000 workers across the globe.

When was STERIS founded?

STERIS was founded in 1987.

What is STERIS's official website?

The official website for STERIS is www.steris.com.

Where are STERIS's headquarters?

STERIS is headquartered at 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296.

How can I contact STERIS?

STERIS's mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]


This page was last updated on 6/25/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.